BSE filing, NSE: FINKURVE. Summary written from the filing by ALFA Finder's alert engine.
Finkurve Financial Services Ltd: key numbers
- Share price
- ₹64.74
- Market cap
- ₹906.7 Cr
- Revenue (annual)
- ₹207.2 Cr
- Net profit (annual)
- ₹26.03 Cr
- P/E (TTM)
- 30.9×Sector 19.5×
- Promoter holding
- 56.21%+0.00% QoQ
- FII holding
- 7.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Finkurve Financial Services Ltd
All →Finkurve Financial Services Investor Presentation: Key Takeaways
Q2FY27 AUM ₹1,311.5 Cr (+95.4% YoY), PAT ₹9.6 Cr (+62.2% YoY), gold loans 95.6% of AUM. Asset quality deteriorated sharply, with NNPA at 2.37%.
Finkurve Financial Services Results Update
Finkurve Financial Services reports Q2 FY27 total income of Rs.90 Crore, up 87.8% YoY, and PAT of Rs.10 Crore. AUM rose 95.4% YoY to Rs.1,312 Crore.
Finkurve Financial Services Q2 FY27 Results: Net Profit ₹9.6 Cr, Up 62.7% YoY
Finkurve Financial Services Ltd reported revenue from operations of ₹89.9 Cr (+87.3% YoY) and net profit of ₹9.6 Cr (+62.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.6 Cr · +62.7% YoY
Finkurve Financial Services Debt & Borrowing: ₹0.43 Cr
Finkurve Financial Services paid Rs. 0.43 Crore combined monthly interest on two listed NCD series on October 30, 2026. This is routine debt servicing.
- Value
- ₹0.43 Cr
Finkurve Financial Services Board Meeting Date
Finkurve Financial Services will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window remains closed as previously intimated.
Finkurve Financial Services Other Announcement
Finkurve clarifies that its NCD interest payment notice (Ann Id 14641482) was wrongly filed as a Regulation 50(1) board meeting intimation. It asks the exchange to disregard that entry.
Other other announcement announcements
All →Kiri Industries Other Announcement
Kiri Industries filed the Crisil monitoring agency report for the quarter ended September 30, 2026. The report covers utilisation of preferential warrant issue proceeds with no deviations.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies appointed Amit Jaste & Associates as Secretarial Auditor for 60 months, effective 5 November 2026. Approved at the same-day board meeting.
- Execution
- 60 months
Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Span Divergent Other Announcement
Span Divergent approved leasing Ahmedabad property to material subsidiary Dryfruit Factory LLP. Rent is capped at ₹3 lakh monthly under an arm's-length related-party transaction.
Cello World Other Announcement
Cello World's QIP monitoring report shows no fund deviation for the quarter ended September 2026. Object 1 is delayed, with Rs.1.51 crore unutilised.
Shree Karni Fabcom Other Announcement
Shree Karni Fabcom confirmed no deviation or variation in utilisation of its preferential warrant issue proceeds for the half-year ended September 30, 2026. The Reg 32 statement shows Rs.2,409.75 lakhs fully utilised as allocated.